The current TXMD market cap is 23.85M. The company's latest EPS is USD 10.5905 and P/E is 0.21.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 20.92M | 1.15M | 416k | 437k | -53k |
Operating Income | -20.75M | 67.01M | -2.67M | -2.47M | -1.77M |
Net Income | -28.97M | 77.7M | -3.6M | -2.41M | -3.38M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 16.1M | 49.65M | 64.87M | 86.95M | 69.96M |
Operating Income | -130.22M | -151.21M | -155.54M | -139.77M | 1.19M |
Net Income | -132.62M | -176.15M | -183.52M | -172.42M | 112M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 133.91M | 90.46M | 59.6M | 53.69M | 50.49M |
Total Liabilities | 182.18M | 55.32M | 27.58M | 22.49M | 22.44M |
Total Equity | -48.27M | 35.14M | 32.02M | 31.2M | 28.05M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 211.98M | 265.99M | 181.61M | 169.47M | 90.46M |
Total Liabilities | 114.46M | 256.79M | 305.61M | 263.09M | 55.32M |
Total Equity | 97.52M | 9.2M | -124M | -93.62M | 35.14M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -63.85M | 9.36M | -33.18M | -12.09M | -40.3M |
Investing | 142.32M | -355k | N/A | N/A | N/A |
Financing | -105.26M | -24.81M | 1.11M | 1.15M | 1.15M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -106.81M | -165.7M | -159.47M | -142.69M | 9.36M |
Investing | -21.5M | -23.91M | -1.6M | -2.22M | -355k |
Financing | 162.79M | 188.83M | 80.72M | 129.55M | -24.81M |
Market Cap | 23.85M |
Price to Earnings Ratio | 0.21 |
Price to Sales Ratio | 0.34 |
Price to Cash Ratio | 0.63 |
Price to Book Ratio | 0.68 |
Dividend Yield | - |
Shares Outstanding | 10.58M |
Average Volume (1 week) | 16.86k |
Average Volume (1 Month) | 26.83k |
52 Week Change | -37.52% |
52 Week High | 4.725 |
52 Week Low | 1.95 |
Spread (Intraday) | 0.05 (2.17%) |
Company Name | TherapeuticsMD Inc |
Address |
318 n carson st carson city, nevada 89701 |
Website | https://www.therapeuticsmd.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.